Skip to main content
Created by potrace 1.11, written by Peter Selinger 2001-2013
NO
Search oslomet.no
  • About OsloMet
  • Study at OsloMet
  • Our research
  • Work for us
  • Alumni
  • University Library
  • Contact us
  1. OsloMet
  2. ...Intermediate levels are hidden
  3. Research projects
  4. Can Motivational Interviewing facilitate return to work in sick-listed people with musculoskeletal disorders? (MI-NAV)

Can Motivational Interviewing facilitate return to work in sick-listed people with musculoskeletal disorders? (MI-NAV)

This project aimed to evaluate the effectiveness of Motivational Interviewing on return to work among sick-listed people due to musculoskeletal disorders. This was a randomised trial within NAV.

Period
01.09.2018 – 31.12.2023
Funding
Norges forskningsråd
Project owner
  • Faculty of Health Sciences (HV)
  • Department of Rehabilitation Science and Health Technology
Project leader
  • Margreth Grotle

Musculoskeletal disorders are the main cause of sickness absence and disability benefits in Norway, and the single leading cause of disability worldwide.

Facilitating return to work and preventing long-term sickness absence are critical concerns for the Norwegian Labour and Welfare Administration (NAV).

The main objective of the project was to evaluate the effectiveness and cost-effectiveness of usual case management alone with usual case management plus Motivational Interviewing (MI) or usual case management plus Stratified Vocational Advice Intervention (SVAI) on return to work among people on sick leave due to musculoskeletal (MSK) disorders.

Project participants

  • Hedda Eik

    Hedda Eik

    • Associate Professor
    • +47 672 36 741
  • Margreth Grotle

    Margreth Grotle

    • Professor
    • +47 672 36 043
  • Milada Hagen

    Milada Hagen

    • Professor
    • +47 672 36 141
  • Tarjei Langseth Rysstad

    • Associate Professor
    • +47 672 36 891
  • Kjersti Storheim

    Kjersti Storheim

    • Professor
    • +47 672 36 803
  • Anne Therese Tveter

    Anne Therese Tveter

    • Professor
    • +47 672 36 774
  • Britt Elin Øiestad

    Britt Elin Øiestad

    • Professor
    • +47 672 36 452

External participants

  • Ida Løchting, Diakonhjemmet Hospital
  • Alexander Tingulstad, Norwegian Medical Products Agency
  • Fiona Aanesen, Sintef
  • Rigmor Berg, Norwegian Labour and Welfare Administration
  • Bjørn Are Hultman, Norwegian Labour and Welfare Administration
  • Kari Paulsen, Norwegian Labour and Welfare Administration
  • Kristel Skorge, Norwegian Labour and Welfare Administration
  • Egil A. Fors, Norwegian University of Science and Technology (NTNU)
  • Roger Hagen, Norwegian University of Science and Technology (NTNU)
  • Lene Aasdahl, Norwegian University of Science and Technology (NTNU)
  • Gunnhild Bagøien, St. Olav's Hospital, Trondheim University Hospital
  • Nadine Foster, University of Queensland, Australia and Keele University, UK
  • Gail Snowden, Keele University, UK
  • Gwen Wynne-Jones, Keele University, UK
  • Aidan Cashin, Neuroscience Research Australia
  • Esther Maas, Vrije University Amsterdam, the Netherlands
  • Maurits van Tulder, Vrije University Amsterdam, the Netherlands

Research groups

  • Centre for Intelligent Musculoskeletal Health (CIM)
Publisert: 22.04.2022Sist oppdatert: 26.02.2026

OSLO METROPOLITAN UNIVERSITY
STORBYUNIVERSITETET

P.O. Box 4, St. Olavs plass
NO-0130 Oslo
Norway
Tel.: +47 67 23 50 00

Contact us

  • Facebook
  • LinkedIn
  • Instagram
  • Norwegian
  • Accessibility statement
  • Cookies policy
  • Employee directory
  • Employee website
  • Student website
  • Upcoming events
  • Work for us

More about the project

The secondary objectives of the project were to investigate

  • the scientific evidence for the use of MI and the current NAV practice on counselling approaches in meetings with people on sick leave due to musculoskeletal disorders
  • the precision of a simple nine-item screening tool in identifying risk profiles among Norwegian people on sick leave due to musculoskeletal disorders
  • the mediating effect of self-efficacy, work ability and change in risk profile on return to work
  • potential predictors for successful outcome at 12 months follow-up.

All data collection in the MI-NAV project has been completed, and a summary for the status for each of the three work packages (WP) is as follows.

Work package 1

In WP1, the scientific evidence for the use of MI and the current NAV practice on counselling approaches in meetings with people on sick leave with musculoskeletal disorders were investigated by conducting a systematic mapping review and a survey and focus group interview of NAV caseworkers on their experiences of the return-to-work process among people with musculoskeletal disorders.

Three papers have been published on results from WP1.

Work package 2

In WP2, we have explored the most accurate screening tool to identify people at a high risk of prolonged sickness absence due to musculoskeletal disorders, and investigated musculoskeletal health, health-related quality-of-life, health care consumption, and costs across different risk profiles in individuals on sick leave due to musculoskeletal disorders.

This was a one-year prospective cohort study of people on sick leave due to musculoskeletal disorders. The study protocol is registered, and three papers have been published from the WP2.

Work package 3

In WP3 a multi-arm randomized controlled trial (RCT) was conducted within the NAV system in Norway. The protocol is published as well as statistical analysis plan for the main analyses.

By autumn 2021 the six months follow-up of 450 included participants, aged 18-67 years, on 50-100 percent sick leave for more than seven weeks due to MSK disorders have been completed.

The primary outcome is the number of sick leave days from randomization to six months follow-up, and the primary analysis is in process and has been completed and results are published in Journal of Occupation and Environmental medicine.

Two process evaluations, one for each intervention, have been conducted, including fidelity of the interventions, and have been published in two papers during 2021.

Cost-utility and cost-benefit analyses will be performed on the six months follow-up data and is in process. The 12 months follow-up was completed in April 2023.